Stellatar Ganglione Blockage for Ventricular Arrhytmias | Clinical Trial | StuddyBuddy@endsection
← Back to all trials
Completed
NCT05712122
Stellatar Ganglione Blockage for Ventricular Arrhytmias
Conditions: Cardiac Arrhythmia
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 10
Sponsor: Adana City Training and Research Hospital
Location: Turkey
Summary
Ventricular tachycardia (VT) and ventricular fibrillation (VF) are life-threatening conditions that increase in frequency over the years.
An electrical storm (ES) is defined as the occurrence of 3 or more continuous ventricular arrhythmia.
The sympathetic nervous system has an important role in VA and is the target of treatment.
Studies show that stellate ganglion blockade (SGB) can reduce cardiac sympathetic tone and is an alternative bridge therapy in VAs.
In our study, the investigators preferred to apply a combination of local anesthetic and steroid in the stellate ganglion blocking method to 10 VA patients who were resistant to medical treatment and had an ICD, and we also planned to examine the 6-month follow-up results of the patients.In our study, USG-guided left stellate ganglion blockade was applied to 10 VA and ES patients with ICD.
The 6-month results of the patients were evaluated retrospectively.
For blockage, the solution was prepared by adding 8 mg dexamethasone, 40 mg lidocaine, and 10 mg bupivacaine to 10 mL with physiological saline.
The success of the procedure was evaluated with the development of Horner's syndrome in the left eye.
Eligibility Criteria
Inclusion Criteria:Ventricular tachycardia (VT)Ventricular fibrillation (VF)Electrical storm (ES)Exclusion Criteria:Resistant ventricular arrhythmia
Source: ClinicalTrials.gov (NCT05712122). StuddyBuddy aggregates publicly available trial information.